Results 21 to 30 of about 693,247 (202)
Investigating isocitrate dehydrogenase mutations in cancer using new metabolomics methods [PDF]
Altered cellular metabolism, as a result of oncogenic mutations, has been observed in a range of cancer types. A detailed understanding of how cancers modify cellular metabolism, which includes changes to the genome, proteome and metabolome, is therefore
Walsby-Tickle, John
core +1 more source
Single arginine mutation in two yeast isocitrate dehydrogenases: biochemical characterization and functional implication. [PDF]
Isocitrate dehydrogenase (IDH), a housekeeping gene, has drawn the attention of cancer experts. Mutation of the catalytic Arg132 residue of human IDH1 (HcIDH) eliminates the enzyme's wild-type isocitrate oxidation activity, but confer the mutant an ...
Ping Song +4 more
doaj +1 more source
Background: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression.
Ronie Romelean Jayapalan +3 more
doaj +1 more source
Succinate dehydrogenase (SDH)-deficient renal carcinoma:a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients [PDF]
Succinate dehydrogenase (SDH)-deficient renal carcinoma has been accepted as a provisional entity in the 2013 International Society of Urological Pathology Vancouver Classification.
Sedivcová, Monika +46 more
core +1 more source
Objectives To explore the characteristics of IDH and TERT promoter mutations in gliomas in Chinese patients. Methods A total of 124 Chinese patients with gliomas were enrolled to study the frequencies of mutations in isocitrate dehydrogenase (IDH) and ...
Chong‐Xiao Qu +5 more
doaj +1 more source
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
Background Non-invasive diagnosis of IDH1 mutation for gliomas has great clinical significance, and PET has natural advantage to detect metabolism, as IDH mutated gliomas share lower glucose consumption. Methods Clinical data of patients with gliomas and
Feng-Min Liu +9 more
doaj +1 more source
The role of isocitrate in control of the phosphorylation of isocitrate dehydrogenase in Escherichia coli ML308 [PDF]
Isocitrate dehydrogenase from Escherichia coli is regulated by a reversible phosphorylation mechanism. We confirm here that this permits intracellular isocitrate to rise to a level that can sustain growth on acetate.
El-Mansi, E.M.T. +5 more
core +1 more source
Background: Reactive gliosis is a response of glial tissue to different types of injury such as brain abscess, trauma, hemorrhage, or even neoplastic process.
Bita Geramizadeh +2 more
doaj +1 more source
The isocitrate dehydrogenase from cyanobacteria
S.73-79The present communication describes the properties of isocitrate dehydrogenase in crude extracts from the unicellular Anacystis nidulans and from heterocysts and vegetative cells of Nostoc muscorum and Anabaena cylindrica.
Refaian, M. +3 more
core +1 more source
Serum isocitrate dehydrogenase activity in Reye's syndrome [PDF]
Serum levels of isocitrate dehydrogenase was determined in 12 Reye's syndrome patients and the enzyme levels were compared with serum ornithine carbamyl phosphate, glutamic oxaloacetic transaminase (aspartate aminotransferase), ammonia, and the stages of
Deshmukh, Devendra R. +2 more
core +1 more source

